Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Moderna 0.145, AstraZeneca 15.288.
Moderna vs AstraZeneca Net Worth and Market Cap
Moderna (MRNA) and AstraZeneca (AZN) are peers in Vaccines. Moderna reported revenue of $145M as of Q2 2026, compared with $15.3B for AstraZeneca. AstraZeneca leads on revenue.
Moderna's gross margin is 35.9% versus 82.5% for AstraZeneca. Moderna's net margin is -539.3% versus 20.1% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Moderna, AstraZeneca.| Metric | Moderna | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $145.00M | $15.29B |
| Cost of Revenue | $93.00M | $2.68B |
| Gross Profit | $52.00M | $12.61B |
| Operating Income | $-815.00M | $4.25B |
| Net Income | $-782.00M | $3.08B |
| R&D Expense | $651.00M | $3.49B |
| Earnings Per Share | -$1.96 | $1.97 |
| Gross Margin | 35.9% | 82.5% |
| Operating Margin | -562.1% | 27.8% |
| Net Profit Margin | -539.3% | 20.1% |
| Free Cash Flow | $-563.00M | $1.82B |
| Cumulative Free Cash Flow | $7.37B | $120.67B |
| Operating Cash Flow | $-526.00M | $3.36B |
| Cash & Equivalents | $1.72B | $7.56B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.